THE INFLUENCE OF TREATMENT WITH CORDAFLEX-RETARD ON LIFE QUALITY OF PATIENTS WITH ARTERIAL HYPERTENSION

We studied the effectiveness and safety of administration of the extended-action calcium antagonist Nifedipin-Retard (Cordaflex-Retard, EGIS) in 30 patients with arterial hypertension of the 1st and 2nd degree. The study included general clinical examination, round-the-clock monitoring of the arteri...

Full description

Saved in:
Bibliographic Details
Main Authors: L. I. Katelnitskaya, I. V. Luzhetskaya, G. O. Treneva, S. G. Kechejieva, L. A. Mahova, N. A. Yelizarov, A. N. Yelizarov
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2001-08-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/2109
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849249862815580160
author L. I. Katelnitskaya
I. V. Luzhetskaya
G. O. Treneva
S. G. Kechejieva
L. A. Mahova
N. A. Yelizarov
A. N. Yelizarov
author_facet L. I. Katelnitskaya
I. V. Luzhetskaya
G. O. Treneva
S. G. Kechejieva
L. A. Mahova
N. A. Yelizarov
A. N. Yelizarov
author_sort L. I. Katelnitskaya
collection DOAJ
description We studied the effectiveness and safety of administration of the extended-action calcium antagonist Nifedipin-Retard (Cordaflex-Retard, EGIS) in 30 patients with arterial hypertension of the 1st and 2nd degree. The study included general clinical examination, round-the-clock monitoring of the arterial pressure (AP) and of the heart rate (HR). Before the therapy and after 6 months of monitoring, examination was performed to assess the life quality and the risk factors, as well as the quantity and quality of health. Cordaflex-Retard was administered depending on the initial AP, in the daily dose of 20 to 40 mg during 24 weeks. We found not only hypotensive action with the AP level stabilization, but also reduction of the magnitude and the rate of the SAP morning rise, as well as a greater degree of the night dipping of the SAP and DAP, accompanied by improvement of the life quality.
format Article
id doaj-art-9e79cbd8a1144b89bbdc7740d9e4bb67
institution Kabale University
issn 1560-4071
2618-7620
language Russian
publishDate 2001-08-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-9e79cbd8a1144b89bbdc7740d9e4bb672025-08-20T03:57:26Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202001-08-010457621862THE INFLUENCE OF TREATMENT WITH CORDAFLEX-RETARD ON LIFE QUALITY OF PATIENTS WITH ARTERIAL HYPERTENSIONL. I. Katelnitskaya0I. V. Luzhetskaya1G. O. Treneva2S. G. Kechejieva3L. A. Mahova4N. A. Yelizarov5A. N. Yelizarov6Ростовский государственный медицинский университетРостовский государственный медицинский университетРостовский государственный медицинский университетРостовский государственный медицинский университетРостовский государственный медицинский университетРостовский государственный медицинский университетРостовский государственный медицинский университетWe studied the effectiveness and safety of administration of the extended-action calcium antagonist Nifedipin-Retard (Cordaflex-Retard, EGIS) in 30 patients with arterial hypertension of the 1st and 2nd degree. The study included general clinical examination, round-the-clock monitoring of the arterial pressure (AP) and of the heart rate (HR). Before the therapy and after 6 months of monitoring, examination was performed to assess the life quality and the risk factors, as well as the quantity and quality of health. Cordaflex-Retard was administered depending on the initial AP, in the daily dose of 20 to 40 mg during 24 weeks. We found not only hypotensive action with the AP level stabilization, but also reduction of the magnitude and the rate of the SAP morning rise, as well as a greater degree of the night dipping of the SAP and DAP, accompanied by improvement of the life quality.https://russjcardiol.elpub.ru/jour/article/view/2109calcium antagonistsnifedipin-retardround-the-clock monitoring of the aplife qualityarterial hypertension
spellingShingle L. I. Katelnitskaya
I. V. Luzhetskaya
G. O. Treneva
S. G. Kechejieva
L. A. Mahova
N. A. Yelizarov
A. N. Yelizarov
THE INFLUENCE OF TREATMENT WITH CORDAFLEX-RETARD ON LIFE QUALITY OF PATIENTS WITH ARTERIAL HYPERTENSION
Российский кардиологический журнал
calcium antagonists
nifedipin-retard
round-the-clock monitoring of the ap
life quality
arterial hypertension
title THE INFLUENCE OF TREATMENT WITH CORDAFLEX-RETARD ON LIFE QUALITY OF PATIENTS WITH ARTERIAL HYPERTENSION
title_full THE INFLUENCE OF TREATMENT WITH CORDAFLEX-RETARD ON LIFE QUALITY OF PATIENTS WITH ARTERIAL HYPERTENSION
title_fullStr THE INFLUENCE OF TREATMENT WITH CORDAFLEX-RETARD ON LIFE QUALITY OF PATIENTS WITH ARTERIAL HYPERTENSION
title_full_unstemmed THE INFLUENCE OF TREATMENT WITH CORDAFLEX-RETARD ON LIFE QUALITY OF PATIENTS WITH ARTERIAL HYPERTENSION
title_short THE INFLUENCE OF TREATMENT WITH CORDAFLEX-RETARD ON LIFE QUALITY OF PATIENTS WITH ARTERIAL HYPERTENSION
title_sort influence of treatment with cordaflex retard on life quality of patients with arterial hypertension
topic calcium antagonists
nifedipin-retard
round-the-clock monitoring of the ap
life quality
arterial hypertension
url https://russjcardiol.elpub.ru/jour/article/view/2109
work_keys_str_mv AT likatelnitskaya theinfluenceoftreatmentwithcordaflexretardonlifequalityofpatientswitharterialhypertension
AT ivluzhetskaya theinfluenceoftreatmentwithcordaflexretardonlifequalityofpatientswitharterialhypertension
AT gotreneva theinfluenceoftreatmentwithcordaflexretardonlifequalityofpatientswitharterialhypertension
AT sgkechejieva theinfluenceoftreatmentwithcordaflexretardonlifequalityofpatientswitharterialhypertension
AT lamahova theinfluenceoftreatmentwithcordaflexretardonlifequalityofpatientswitharterialhypertension
AT nayelizarov theinfluenceoftreatmentwithcordaflexretardonlifequalityofpatientswitharterialhypertension
AT anyelizarov theinfluenceoftreatmentwithcordaflexretardonlifequalityofpatientswitharterialhypertension
AT likatelnitskaya influenceoftreatmentwithcordaflexretardonlifequalityofpatientswitharterialhypertension
AT ivluzhetskaya influenceoftreatmentwithcordaflexretardonlifequalityofpatientswitharterialhypertension
AT gotreneva influenceoftreatmentwithcordaflexretardonlifequalityofpatientswitharterialhypertension
AT sgkechejieva influenceoftreatmentwithcordaflexretardonlifequalityofpatientswitharterialhypertension
AT lamahova influenceoftreatmentwithcordaflexretardonlifequalityofpatientswitharterialhypertension
AT nayelizarov influenceoftreatmentwithcordaflexretardonlifequalityofpatientswitharterialhypertension
AT anyelizarov influenceoftreatmentwithcordaflexretardonlifequalityofpatientswitharterialhypertension